The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, X.-L.
Right arrow Articles by Chamberlain, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, X.-L.
Right arrow Articles by Chamberlain, J. W.
The Journal of Immunology, 1998, 161: 2254-2266.
Copyright © 1998 by The American Association of Immunologists

Distinct Stage-Specific cis-Active Transcriptional Mechanisms Control Expression of T Cell Coreceptor CD8{alpha} at Double- and Single-Positive Stages of Thymic Development1

Xiao-Li Zhang*, Rho Seong2,{dagger}, Rafia Piracha*, Mani Larijani*, Matthew Heeney*, Jane R. Parnes{dagger} and John W. Chamberlain3,*

* Research Institute, Hospital For Sick Children, and Department of Immunology, University of Toronto, Toronto, Ontario, Canada; and {dagger} Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305

Developing thymocytes that give rise to CD8+ (cytotoxic) and CD4+ (helper) {alpha}ß-TCR T lymphocytes go through progressive stages of expression of coreceptors CD8 and CD4 from being negative for both (the double-negative stage), to coexpressing both (the double-positive (DP) stage), to a mutually exclusive sublineage-specific expression of one or the other (the single-positive (SP) stage). To delineate the mechanisms underlying regulation of CD8 during these developmental transitions, we have examined expression of a series of mouse CD8{alpha} gene constructs in developing T cells of conventional and CD8{alpha} "knock-out" transgenic mice. Our results indicate that cis-active transcriptional control sequences essential for stage- and sublineage-specific expression lie within a 5' 40-kb segment of the CD8 locus, ~12 kb upstream of the CD8{alpha} gene. Studies to characterize and sublocalize these cis sequences showed that a 17-kb 5' subfragment is able to direct expression of the CD8{alpha} gene up to the CD3intermediate DP stage but not in more mature DP or SP cells. These results indicate that stage-specific expression of CD8{alpha} in developing T cells is mediated by the differential activity of multiple functionally distinct cis-active transcriptional control mechanisms. It will be important to determine the relationship of "switching" between these cis mechanisms and selection.




This article has been cited by other articles:


Home page
JEMHome page
P. Aliahmad and J. Kaye
Development of all CD4 T lineages requires nuclear factor TOX
J. Exp. Med., January 21, 2008; 205(1): 245 - 256.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. J. Kieffer, J. M. Greally, I. Landres, S. Nag, Y. Nakajima, T. Kohwi-Shigematsu, and P. B. Kavathas
Identification of a Candidate Regulatory Region in the Human CD8 Gene Complex by Colocalization of DNase I Hypersensitive Sites and Matrix Attachment Regions Which Bind SATB1 and GATA-3
J. Immunol., April 15, 2002; 168(8): 3915 - 3922.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
X.-L. Zhang, S. Zhao, S.H. Borenstein, Y. Liu, B. Jayabalasingham, and J.W. Chamberlain
Cd8 Expression up to the Double-Positive CD3Low/Intermediate Stage of Thymic Differentiation Is Sufficient for Development of Peripheral Functional Cytotoxic T Lymphocytes
J. Exp. Med., September 3, 2001; 194(5): 685 - 694.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
B. Reizis and P. Leder
Expression of the Mouse Pre-T Cell Receptor {alpha} Gene Is Controlled by an Upstream Region Containing a Transcriptional Enhancer
J. Exp. Med., May 17, 1999; 189(10): 1669 - 1678.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.